Digital Marketing Trends in Inflammatory Bowel Disease
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Inflammatory Bowel Disease Report Overview
AbbVie’s Skyrizi.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, with over 1.8 million visitors from March 2023 to February 2024. This was followed by AbbVie’s Rinvoq.com with 1.4 million visits. Overall, the highest proportion of traffic to top branded patient IBD websites originated from paid sources, followed by organic sources.
Buy the Full Report to Get More Insights into the Digital Marketing Trends in Inflammatory Bowel Disease or Download a Free Report Sample
The ‘Digital Marketing Trends in Inflammatory Bowel Disease’ report provides an analysis of key digital marketing metrics of pharma assets in IBD, including branded websites for patients and HCPs, unbranded websites, and social media accounts. Furthermore, the report enlists metrics such as website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
| Key US Branded Websites for Patients | · Skyrizi.com
· Rinvoq.com · Entyvio.com · Humira.com · Zeposia.com · Others |
| Key US Branded Websites for HCP | · Rinvoqhcp.com
· Entyviohcp.com · Skyrizihcp.com · Humirapro.com · Stelarahcp.com · Others |
| Key US Unbranded Websites | · AbbVie’s Crohnsandcolitis.com
· Takeda’s Ibdandme.org |
| Key EUCAN Branded Websites | · Abbvie-care.de
· Abbviecare.fr · Abbviecare.es · Abbviecare.ca |
| Key EUCAN Unbranded Websites | · Takeda’s Ced-trotzdem-ich.de
· AbbVie’s Leben-mit-ced.de |
| Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Key US Patient Branded Websites for Inflammatory Bowel Disease
The key US-branded patient websites for inflammatory bowel disease are Skyrizi.com, Rinvoq.com, Entyvio.com, Humira.com, Zeposia.com, and others. Skyrizi.com achieved the highest total traffic across IBD patient sites in the US followed by Rinvoq.com.
Digital Marketing Trends in Inflammatory Bowel Disease Analysis by the US Patient Branded Websites, March 2023-February 2024
Buy the Full Report to Get More Insights into the US Patient Branded Websites for Inflammatory Bowel Disease or Download a Free Report Sample
Key US HCP Branded Websites for Inflammatory Bowel Disease
The key US HCP-branded websites for inflammatory bowel disease are Rinvoqhcp.com, Entyviohcp.com, Skyrizihcp.com, Humirapro.com, Stelarahcp.com, and others. Rinvoqhcp.com achieved the highest traffic across IBD HCP sites from March 2023 to February 2024.
Digital Marketing Trends in Inflammatory Bowel Disease Analysis by the US HCP Branded Websites, March 2023-February 2024
Buy the Full Report to Get More Insights into the US HCP Branded Websites for Inflammatory Bowel Disease or Download a Free Report Sample
Key US Unbranded Websites for Inflammatory Bowel Disease
A few of the key US unbranded websites are AbbVie’s Crohnsandcolitis.com and Takeda’s Ibdandme.org. AbbVie’s Crohnsandcolitis.com had the highest traffic between March 2023 and February 2024.
Digital Marketing Trends in Inflammatory Bowel Disease Analysis by the US Unbranded Websites, March 2023-February 2024
Buy the Full Report to Get More Insights into the US Unbranded Websites for Inflammatory Bowel Disease or Download a Free Report Sample
Key EUCAN Branded Websites for Inflammatory Bowel Disease
A few of the key EUCAN-branded websites are Abbvie-care.de, Abbviecare.fr, Abbviecare.es, and Abbviecare.ca. Abbvie-care.de achieved the highest total traffic across IBD-branded sites in EUCAN between March 2023 and February 2024.
Digital Marketing Trends in Inflammatory Bowel Disease Analysis by the EUCAN Branded Websites, March 2023-February 2024
Buy the Full Report to Get More Insights into the EUCAN Branded Websites for Inflammatory Bowel Disease or Download a Free Report Sample
Key EUCAN Unbranded Websites for Inflammatory Bowel Disease
A few of the key EUCAN unbranded websites are Takeda’s Ced-trotzdem-ich.de and AbbVie’s Leben-mit-ced.de. Takeda’s Ced-trotzdem-ich.de in Italy had the highest traffic across all unbranded IBD sites in EUCAN between March 2023 and February 2024.
Digital Marketing Trends in Inflammatory Bowel Disease Analysis by the EUCAN Unbranded Websites, March 2023-February 2024
Buy the Full Report to Get More Insights into the EUCAN Unbranded Websites for Inflammatory Bowel Disease or Download a Free Report Sample
Scope
- The report assesses key digital marketing metrics of pharma assets in IBD including branded websites for patients and HCPs, unbranded websites, and social media accounts.
- The report includes metrics such as website traffic volume, engagement, source, DDA, paid SEO, and social media post interaction.
- The report includes countries such as the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in IBD to lead patient and HCP branded assets across different regions.
- Get what strategies pharma companies are using to drive traffic to their IBD branded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded and unbranded assets for patients by how they address and support different patient needs.
Takeda
Table of Contents
Frequently asked questions
-
Which are the key US-branded websites for patients?
The key US-branded websites for patients are Skyrizi.com, Rinvoq.com, Entyvio.com, Humira.com, Zeposia.com, and others.
-
Which website achieved the highest traffic across IBD HCP sites from March 2023 to February 2024?
Rinvoqhcp.com achieved the highest traffic across IBD HCP sites from March 2023 to February 2024.
-
Which are the key EUCAN unbranded websites?
A few of the key EUCAN unbranded websites are Takeda’s Ced-trotzdem-ich.de and AbbVie’s Leben-mit-ced.de.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Inflammatory Bowel Disease reports




